Functional immune characterization of HIV-associated non-small-cell lung cancer.
暂无分享,去创建一个
P. Oliveri | A. Akarca | T. Marafioti | E. Suardi | D. Pinato | R. Shiner | F. Mauri | E. Allara | M. Bower | T. Newsom-Davis | P. Trivedi | A. Dalla Pria | A. Kythreotou | N. Gupta
[1] A. Samri,et al. Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] C. Hamard,et al. Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates , 2017, AIDS.
[3] Antoni Ribas,et al. Classifying Cancers Based on T-cell Infiltration and PD-L1. , 2015, Cancer research.
[4] J. Taube,et al. Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy , 2014, Clinical Cancer Research.
[5] B. Gazzard,et al. HIV-related lung cancer in the era of highly active antiretroviral therapy , 2003, AIDS.